Other Income & Expense
Other Income (Expense)
Eli Lilly Other Income (Expense) increased by 40.0% to -$65.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 72.8%, from -$239.00M to -$65.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 41.5% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $190.50M | -$635.90M | -$77.30M | -$350.70M | -$119.20M | -$111.00M | $35.70M | -$36.80M | -$23.20M | $121.30M | $27.10M | -$197.60M | $62.00M | -$110.50M | -$239.00M | -$90.60M | -$133.10M | -$108.30M | -$65.00M |
| QoQ Change | — | -433.8% | +87.8% | -353.7% | +66.0% | +6.9% | +132.2% | -203.1% | +37.0% | +622.8% | -77.7% | -829.2% | +131.4% | -278.2% | -116.3% | +62.1% | -46.9% | +18.6% | +40.0% |
| YoY Change | — | — | — | — | -162.6% | +82.5% | +110.2% | +69.1% | +79.1% | — | -24.1% | -437.0% | +367.2% | -191.1% | -981.9% | +54.1% | -314.7% | +2.0% | +72.8% |
Range-$635.90M – $190.50M
CAGR-21.3%
Avg YoY Growth-91.0%
Median YoY Growth+28.1%
Current Streak2 quarters growth
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other income (expense)?
- Eli Lilly (LLY) reported other income (expense) of -$65.00M in Q1 2026.
- How has Eli Lilly's other income (expense) changed year-over-year?
- Eli Lilly's other income (expense) increased by 72.8% year-over-year, from -$239.00M to -$65.00M.
- What is the long-term trend for Eli Lilly's other income (expense)?
- Over 3 years (2021 to 2025), Eli Lilly's other income (expense) has grown at a 41.5% compound annual growth rate (CAGR), from -$201.60M to -$571.00M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.